A multicenter phase II trial of ZD6474, a vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinase inhibitor, in patients with previously treated metastatic breast cancer

Kathy D. Miller, Jose Manuel Trigo, Catherine Wheeler, Alan Barge, Jacqui Rowbottom, George Sledge, Jose Baselga

Research output: Contribution to journalArticle

181 Scopus citations

Fingerprint Dive into the research topics of 'A multicenter phase II trial of ZD6474, a vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinase inhibitor, in patients with previously treated metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences